Biodistribution and radiation dosimetry of [ 99m Tc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer.
Andreas RinscheidAlexander GäbleGeorgine WienandAlexander DierksMalte KircherThomas GüntherMarianne PattRalph A BundschuhConstantin LapaChristian H PfobPublished in: EJNMMI research (2024)
Tc-labelled SPECT agent could contribute to a broader application and better availability of this novel approach. Further research to assess its clinical value is warranted.